VivoSeq
Infectious Disease

Long COVID

6

Pipeline Programs↗

12

Active Trials↗

4

Companies Involved↗

Long COVID is an early-stage landscape with 6 programs across 4 companies. The most active players are Neurim Pharmaceuticals Ltd., Solvay Pharmaceuticals, Laurent Pharmaceuticals Inc..

Intelligence

Pipeline Metrics

Competitive Density

38/100

Pipeline Velocity

30/100

Mech. Concentration

50/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

N

Neurim Pharmaceuticals Ltd.

1 program

Phase 2S

Solvay Pharmaceuticals

1 program

PreclinicalL

Laurent Pharmaceuticals Inc.

0 programs

PreclinicalR

Resolve Therapeutics

0 programs

Preclinical

Pipeline

Programs by Phase

Analysis

Trial Status

28

clinical trials

Completed14 · 50%
Recruiting8 · 29%
Not yet recruiting3 · 11%
Unknown status2 · 7%
Active, not recruiting1 · 4%

Clinical Trials

Trial Activity

28 trials

AT1001 for the Treatment of Long COVID
Recruiting·MMassachusetts General Hospital·Phase 2·NCT05747534·150 enrolled
Dysbiosis & Long COVID
Recruiting·UUniversity of Chicago·N/A·NCT06825819·400 enrolled
Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
Recruiting·—·Phase 3·NCT06928272·348 enrolled
NE3107 in Adults With Neurological Symptoms of Long COVID
Recruiting·BBioVie Inc.·Phase 2·NCT06847191·208 enrolled
Effect of 2-HOBA in Persistent Immune Activation in Long COVID POTS
Recruiting·VVanderbilt University Medical Center·Phase 2·NCT07189936·50 enrolled
Taurine Supplementation in Long COVID
Recruiting·UUniversity of Alberta·Phase 2/3·NCT06721949·300 enrolled
PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)
Recruiting·National Institute of Mental Health (NIMH)·Phase 1·NCT06920628·60 enrolled
Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)-Outreach: A Scalable, Risk-Based Model for Managing Persistent Cardiovascular Impact in Long COVID
Recruiting·University of Tasmania·Preclinical·NCT07661862·577 enrolled
The Long COVID Treatment Trial
Active, not recruiting·SScripps Translational Science Institute·Phase 2·NCT07128082·1,000 enrolled
Fatigue in Long COVID Managed With Conservative Care: An International, Randomized Controlled Trial (FALCON Trial)
Not yet recruiting·MMcMaster University·Preclinical·NCT07697261·100 enrolled
A Pilot Randomized Controlled Trial of Homeopathic Treatment for Long COVID
Not yet recruiting·SSt. Mary's University, Twickenham·Preclinical·NCT07694232·120 enrolled
An Open-Label Study of Taurine Supplementation in Adolescents With Post-COVID Condition: Quantifying Taurine Plasma Levels and Evaluating Clinical and Biological Outcomes
Not yet recruiting·UUniversity of Alberta·Preclinical·NCT07682402·30 enrolled
Feasibility of Cannabidiol for the Treatment of Long COVID
Completed·—·Phase 2·NCT04997395·12 enrolled
Paxlovid for Treatment of Long Covid
Completed·SStanford University·Phase 2·NCT05576662·168 enrolled
Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
Completed·JJonathann Kuo, MD·Phase 1·NCT05638620·20 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)